PBE

Featured

Big Biotech ETF Still in Uptrend…For Now

By Tom LydonMarch 26, 2014

Featured

Health Care ETFs Raking in Plenty of Cash

By Todd ShriberMarch 6, 2014

Featured

Why This Biotech ETF Leads the Pack

By Todd ShriberFebruary 21, 2014

Equity ETFs

Health Care Heaven: Sector’s ETFs Flex Their Muscles

By Todd ShriberFebruary 14, 2014

Featured

The One ETF Really Benefiting From the Intercept Pharma News

By Todd ShriberJanuary 9, 2014

Featured

Intense Duel to be 2013’s Best Health Care ETF

By Tom LydonDecember 23, 2013

Featured

Biotech ETFs: More Tricks Than Treats in October

By Max ChenOctober 31, 2013

Featured

Sell-Off in Biotech ETFs Could Be a Temporary Setback

By Tom LydonOctober 10, 2013

Featured

10 ETF Investments That Got the Most Bang for Your Buck

By Tom LydonOctober 8, 2013

Featured

Three ETFs to Play Up-and-Coming Health Care Companies

By Tom LydonSeptember 3, 2013

Featured

Three ETFs to Play the Outperforming Biotech Sector

By Tom LydonAugust 19, 2013

Featured

Choosing the Right Biotech ETF Exposure

By Tom LydonApril 20, 2012

Featured

Biotech ETFs Mixed After Gilead Subpoena

By Tom LydonJune 13, 2011

Featured

5 Biotechnology ETFs to Play Innovation

By Tom LydonFebruary 22, 2011

Featured

Why Health Care ETFs May Be In the Clear

By Tom LydonNovember 10, 2010

Featured

5 Things That Drive Biotech ETFs

By Tom LydonOctober 21, 2010

Featured

Biotech ETFs:The Better Way to Play

By Tom LydonOctober 11, 2010

Featured

Biotech ETFs: 5 Ways to Play Innovation

By Tom LydonAugust 8, 2010